June 5, 2015 Prachi Gupta

After being rejected twice, it looks flibanserin, the low libido drug for women, will become FDA-approved. If so, the drug will become the first sexual arousal for women on the market. The New Scientist reports that an FDA advisory panel approved it 18 to 6 on Thursday, provided that it comes “with a risk management […]

Read More…